A Splash With MASH
Learn more about which patients are at greatest risk for metabolic dysfunction-associated steatohepatitis (MASH) and the data for new and emerging therapies in this area.
Learn more about which patients are at greatest risk for metabolic dysfunction-associated steatohepatitis (MASH) and the data for new and emerging therapies in this area.
Spondyloarthritis Faculty Panel Q&A – featuring Drs. Eric Ruderman, Lihi Eder, and Lianne Gensler; moderated by Dr. Artie Kavanaugh
This review examines treatment of opioid use disorder in the era of fentanyl use.
The US Preventive Services Task Force (USPSTF) last released recommendations on breast cancer screening in 2016, when they recommended that most women be screened every…
New AMA data shows which physician specialties have the highest rates of burnout. Learn more from the AMA’s exclusive survey data.
Lab test regulations, the opioid crisis, high medical bills, toxic gas, covid vaccines, vaping dangers, cancer, and more are in the news.
Demand for GLP-1s and other weight loss drugs has yet to subside, and a new study aims to establish an ethical framework that can be…
TUESDAY, April 30, 2024 (HealthDay News) — All women should start getting mammograms every other year beginning at age 40, the nation’s top panel of…
Pu and Qi discover that deactivating V-ATPase, causing lysosomal dysfunction, boosts innate immunity against bacterial infections through UPRmt activation. However, this comes at the expense…
New research adds to understanding of an understudied link
Dr. John Whyte the Chief Medical Officer at WebMD has tips for allergy sufferers this spring.